HUTCHMED (China) (HMDCF) Receivables - Net (2015 - 2025)
HUTCHMED (China) (HMDCF) reported Receivables - Net of $16.3 million for Q4 2025, down 18.54% year-over-year from $20.0 million in Q4 2024, and down 88.91% quarter-over-quarter from $147.0 million in Q2 2025.
HUTCHMED (China) (HMDCF) Receivables - Net (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has 11 years of Receivables - Net data on file, last reported at $16.3 million in Q4 2025.
- Receivables - Net for Q4 2025 came in at $16.3 million, down 18.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.3 million (down 18.54% YoY), and the FY2025 annual result was $16.3 million, up 142.28% from the prior year.
- Receivables - Net slipped to $16.3 million in Q4 2025 per HMDCF's latest filing, from $147.0 million in the prior quarter.
- Over five years, Receivables - Net peaked at $15.0 billion in Q4 2023 and troughed at $10.7 million in Q4 2021.
- A 5-year average of $1.4 billion and a median of $20.1 million in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net jumped 119327.04% in 2023, then plunged 99.87% in 2024.
- A 5-year view of Receivables - Net shows it stood at $10.7 million in 2021, then rose by 16.75% to $12.5 million in 2022, then jumped by 119327.04% to $15.0 billion in 2023, then sank by 99.87% to $20.0 million in 2024, then decreased by 18.54% to $16.3 million in 2025.
- Business Quant data shows HMDCF's Receivables - Net at $16.3 million in Q4 2025, $147.0 million in Q2 2025, and $20.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | HUTCHMED (China) | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.30 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Jun 30, 2025 | 146.97 Mn |
| Jun 30, 2025 | 146.97 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Jun 30, 2024 | 20.07 Mn |
| Jun 30, 2024 | 20.07 Mn |
| Dec 31, 2023 | 14.96 Bn |
| Dec 31, 2023 | 14.96 Bn |
| Jun 30, 2023 | 16.48 Mn |
| Jun 30, 2023 | 16.48 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Jun 30, 2022 | 77.08 Mn |
| Jun 30, 2022 | 77.08 Mn |
| Dec 31, 2021 | 10.73 Mn |
| Dec 31, 2021 | 10.73 Mn |
| Jun 30, 2021 | 57.95 Mn |
| Jun 30, 2021 | 57.95 Mn |